Stock futures are pointing to a lower open for major indexes on Tuesday ahead of announcements on new tariffs the Trump administration has said will be implemented this week.

Stay with Moneycontrol to get real time updates on US MARKET share price, top gainers, top losers and market insights.

The US indices have all seen a lot of losses in the recent past. However, Monday was a nice bounce for them, and Tuesday could end up being massive in its implications.

Adding to concerns, a University of Michigan survey showed consumers’ 12-month inflation expectations soared to the highest in nearly 2-1/2 years in March

The Dow Jones Industrial Average (DJIA) slid on Wednesday as investors remained uncertain about President Trump’s economic plans. That includes

The CNN Money Fear and Greed index showed a decline in the overall market sentiment, while the index moved to the “Extreme Fear” zone on Friday. U.S. stocks settled lower on Friday, with the Dow Jones index falling more than 700 points during the session as investors assessed recent tariff-related news.

Based on Wall Street analyst estimates for 2025 EPS, Amgen trades at 15 times its projected earnings, while Merck sits at a forward P/E of 10. By this measure, Merck is the cheaper stock and a relative bargain, reinforced by its larger dividend yield of 3.4% compared to Amgen's 2.9%.

Mike Armstrong, president of Armstrong Advisory Group, discusses uncertainty around tariffs, managing finances and fluctuations in consumer spending.